Drug utilization review definition

Drug utilization review means an evaluation of a prescription drug order and patient records for

Drug utilization review means evaluating prescription drug order in light of the information currently provided to the pharmacist by the patient or the patient's agent and in light of the information contained in the patient's record for the purpose of promoting therapeutic appropriateness by identifying potential problems and consulting with the prescriber, when appropriate. Problems subject to identification during drug utilization review include, but are not limited to:¶

Drug utilization review means an evaluation of a prescription drug order and patient records for duplication of therapy, interactions, proper utilization, and optimum therapeutic outcomes. The term includes but is not limited to the following evaluations:

Examples of Drug utilization review in a sentence

• The Pharmacy Director shall oversee all pharmacy benefits under this Contract as outlined in Section 3.4. This individual shall represent the Contractor at all meetings of the State’s Drug Utilization Review (DUR) Board meetings and the Mental Health Quality Assurance Advisory Committee (MHQAC).

• As used in this section:11 “Generic drug product” means a drug product that is approved12 and designated by the federal Food and Drug Administration as a13 therapeutic equivalent for a reference listed drug product, including14 a drug product listed in the New Jersey Generic Formulary by the15 Drug Utilization Review Council pursuant to P.L.1977, c.240 16 (C.24:6E-1 et al.).17 “Prescriber” means a licensed health care professional who is18 authorized to prescribe the medication pursuant to State law.19 c.

• Magellan Medicaid Administration has brought this technology to the Drug Utilization Review (DUR) Board which allows the Board to make recommendations for edits to address the therapeutic appropriateness of drug regimens to the Agency for implementation via the POS system.

• It shoulddescribe FFY 2021 highlights of theprogram, FFS initiatives, improvements, program oversight of managed care partners when applicable, and statewide (FFS and MCO) initiatives.I. Drug Utilization Review Program Overview Magellan Medicaid Administration provides electronic claims processing and a pharmacy claims management system incorporating on-line point-of-service (POS) and prospective drug utilization review (ProDUR) for the Florida Medicaid Fee-for-Service (FFS) Program.

• As used in this section:3 “Generic drug product” means a drug product that is approved4 and designated by the federal Food and Drug Administration as a5 therapeutic equivalent for a reference listed drug product, including6 a drug product listed in the New Jersey Generic Formulary by the7 Drug Utilization Review Council pursuant to P.L.1977, c.240 8 (C.24:6E-1 et al.).9 “Prescriber” means a licensed health care professional who is10 authorized to prescribe the medication pursuant to State law.11 c.

More Definitions of Drug utilization review

Drug utilization review or "DUR" means the program designed to measure and assess, on a retrospective and prospective basis, the proper use of outpatient drugs in the Medicaid program.

Drug utilization review means the process for the retrospective and prospective review and approval of drug use based on criteria and standards employed by the agency to evaluate the medical necessity of reimbursing for covered outpatient drugs.

Drug utilization review. (DUR) means evaluating or reviewing the patient record in order to determine the appropriateness of the drug therapy for a patient and which includes the prospective drug review in

Drug utilization review or “DUR” means the process whereby the therapeutic effects and cost effectiveness of various drug therapies are reviewed, monitored and acted upon consistent with the Member’s Benefit Plan. DUR can be prospective, concurrent or retrospective.

Drug utilization review or "DUR" means evaluation of a prescription to identify and resolve potential problems through the review of information provided to the Pharmacist by the patient, patient's agent, prescriber and the patient's record.

Drug utilization review or “DUR” means a clinical evaluation process within DPIN that evaluates a drug prescription against the patient’s drug history and determines if there will be any adverse effect or precaution associated with the prescribed drug;

Drug utilization review means a system for monitoring the